Drug profile · INN
remifentanil hydrochloride
REMIFENTANIL HYDROCHLORIDE
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
remifentanil hydrochloride (REMIFENTANIL HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12269155
Multivalent vaccines for rabies virus and coronaviruses
granted -
US 12227584
Multivalent and multispecific OX40-binding fusion proteins
granted -
US 12187804
Multivalent and multispecific 41BB-binding proteins
granted -
US 11976126
Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells
granted -
US 11938221
Multivalent nanoparticle-based vaccines
granted -
US 11235054
Multivalent vaccine composition
granted -
US 11191727
Multivalent nanoparticle-based vaccines
granted -
US 11117972
Multivalent and multispecific OX40-binding fusion proteins
granted
Frequently asked questions
What is remifentanil hydrochloride?
remifentanil hydrochloride (REMIFENTANIL HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for remifentanil hydrochloride?
REMIFENTANIL HYDROCHLORIDE is a marketed brand name for remifentanil hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of remifentanil hydrochloride?
remifentanil hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.